PTLA
Portola Pharmaceuticals, Inc.
PTLA
PTLA
Delisted
PTLA was delisted on the 1st of July, 2020.
171 hedge funds and large institutions have $2.11B invested in Portola Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 69 increasing their positions, 54 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
171
Holders Change
+11
Holders Change %
+6.88%
% of All Funds
4.78%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
22
Increased
69
Reduced
54
Closed
10
Calls
$2.9M
Puts
$10.1M
Net Calls
-$7.23M
Net Calls Change
-$11M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$45.1M |
| 2 |
RG
2
Redmile Group
San Francisco,
California
|
$32.8M |
| 3 |
3
Citigroup
New York
|
$25.6M |
| 4 |
4
Norges Bank
Oslo,
Norway
|
$17.9M |
| 5 |
5
VOYA Investment Management
Atlanta,
Georgia
|
$12M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CSS
176
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$356K | -7,813 | Closed |
|
|
ICAS
177
Investors Capital Advisory Services
Lynnfield,
Massachusetts
| – | -$321K | -7,067 | Closed |
|
178
Simplex Trading
Chicago,
Illinois
| – | -$233K | -5,129 | Closed |
|
|
GCP
179
GSA Capital Partners
London,
United Kingdom
| – | -$223K | -4,900 | Closed |
|
|
SCA
180
Secor Capital Advisors
New York
| – | -$217K | -4,768 | Closed |
|
|
TRCT
181
Tower Research Capital (TRC)
New York
| – | -$52K | -1,140 | Closed |
|